North America NGS Automation Market: Trends, Opportunities, and Key Drivers to 2031

• By Product: In 2024, workstations/robotic platforms are expected to dominate the market, attributed to the advantages of automated NGS library preparation, including higher efficiency, reduced turnaround times, lower per-sample costs, and greater reproducibility over manual methods. This segment also sees strong demand from pharmaceutical and biotechnology companies for drug discovery purposes.

• By Sequencing Type: Whole genome sequencing is projected to hold the largest market share in 2024, driven by the growing use of NGS in identifying novel drug targets and developing advanced therapeutic techniques, such as targeted, gene, and oligonucleotide therapies.
• By Application: The drug discovery segment is expected to lead the market, with increasing utilization of NGS to identify novel drug targets and develop therapies targeting specific genes and proteins.

• By End User: The pharmaceutical and biotechnology companies segment is anticipated to maintain the largest market share, thanks to rising R&D investments and the increasing demand for new drug discoveries leveraging advanced NGS technologies.

• By Country: The U.S. is expected to hold the largest market share in 2024, supported by robust R&D investments in the pharmaceutical and biotechnology industries, the presence of key NGS automation platform providers, government initiatives promoting genomics research, rising cancer rates, and a favorable reimbursement environment for NGS-based diagnostics.